Vincenzo Silani
- Neurology top 0.05%
- Genetics top 0.05%
- Molecular Biology top 1%
- Cellular and Molecular Neuroscience top 0.5%
- Physiology top 1%
- Co-authors
- Antonia RattiAndrea CiammolaNicola TicozziBarbara PolettiClaudia ColombritaGian Domenico BorasioLidia CovaSharon Abrahams
- Topics
- Amyotrophic Lateral Sclerosis Research (182 papers)Neurogenetic and Muscular Disorders Research (100 papers)Parkinson's Disease Mechanisms and Treatments (95 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Vincenzo Silani
360 papers receiving 12.6k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Neurology 7.8k
- Genetics 4.5k
- Molecular Biology 4.4k
- Cellular and Molecular Neuroscience 3.1k
- Physiology 1.5k
Countries citing papers authored by Vincenzo Silani
This map shows the geographic impact of Vincenzo Silani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Silani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Silani more than expected).
Fields of papers citing papers by Vincenzo Silani
This network shows the impact of papers produced by Vincenzo Silani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Silani. The network helps show where Vincenzo Silani may publish in the future.
Co-authorship network of co-authors of Vincenzo Silani
This figure shows the co-authorship network connecting the top 25 collaborators of Vincenzo Silani. A scholar is included among the top collaborators of Vincenzo Silani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincenzo Silani. Vincenzo Silani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 12 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 25 | |
| 11 | 1 | |
| 12 | 8 | |
| 13 | 20 | |
| 14 | 2 | |
| 15 | 17 | |
| 16 | 9 | |
| 17 | 99 | |
| 18 | 74 | |
| 19 | 227 | |
| 20 | Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? | 1 |
About Vincenzo Silani
Vincenzo Silani is a scholar working on Neurology, Genetics and Neurology, having authored 369 papers that have together received 12.9k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (182 papers), Neurogenetic and Muscular Disorders Research (100 papers) and Parkinson's Disease Mechanisms and Treatments (95 papers). The work is most often cited by research in Neurology (7.8k citations), Genetics (4.5k citations) and Cellular and Molecular Neuroscience (3.1k citations). Vincenzo Silani has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Antonia Ratti, Andrea Ciammola, Nicola Ticozzi, Barbara Poletti, Claudia Colombrita, Gian Domenico Borasio, Lidia Cova, Sharon Abrahams, Orla Hardiman and Markus Weber. Their work appears in journals such as Science, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.